- Home
- MKL vs TEVA Comparison
MKL vs TEVA Comparison
Compare MKL & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKL
- TEVA
- Stock Information
- Founded
- MKL 1930
- TEVA 1901
- Country
- MKL United States
- TEVA Israel
- Employees
- MKL N/A
- TEVA N/A
- Industry
- MKL Property-Casualty Insurers
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- MKL Finance
- TEVA Health Care
- Exchange
- MKL Nasdaq
- TEVA Nasdaq
- Market Cap
- MKL 24.4B
- TEVA 21.2B
- IPO Year
- MKL 1986
- TEVA N/A
- Fundamental
- Price
- MKL $2,035.00
- TEVA $24.02
- Analyst Decision
- MKL Hold
- TEVA Strong Buy
- Analyst Count
- MKL 2
- TEVA 7
- Target Price
- MKL $1,930.50
- TEVA $25.86
- AVG Volume (30 Days)
- MKL 43.2K
- TEVA 12.0M
- Earning Date
- MKL 10-29-2025
- TEVA 11-05-2025
- Dividend Yield
- MKL N/A
- TEVA N/A
- EPS Growth
- MKL N/A
- TEVA N/A
- EPS
- MKL 142.27
- TEVA 0.62
- Revenue
- MKL $16,210,307,000.00
- TEVA $16,776,000,000.00
- Revenue This Year
- MKL N/A
- TEVA $4.11
- Revenue Next Year
- MKL $0.39
- TEVA $0.40
- P/E Ratio
- MKL $14.32
- TEVA $39.64
- Revenue Growth
- MKL N/A
- TEVA 0.02
- 52 Week Low
- MKL $1,620.61
- TEVA $12.47
- 52 Week High
- MKL $2,075.92
- TEVA $25.00
- Technical
- Relative Strength Index (RSI)
- MKL 65.93
- TEVA 76.02
- Support Level
- MKL $1,943.75
- TEVA $20.11
- Resistance Level
- MKL $1,976.79
- TEVA $25.00
- Average True Range (ATR)
- MKL 34.68
- TEVA 0.70
- MACD
- MKL 16.64
- TEVA 0.50
- Stochastic Oscillator
- MKL 99.22
- TEVA 83.00
About MKL Markel Group Inc.
Markel's primary business is property and casualty insurance. The company focuses primarily on specialty lines, ranging from areas such as executive liability to commercial equine insurance. The acquisition of Alterra in 2013 added substantial reinsurance operations, which now account for a little over 10% of premiums. The company uses capital generated by its insurance operations to buy noninsurance operations in diverse areas, such as bakery equipment manufacturing and residential homebuilding.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.